Edavarone – (89-25-8)

Edaravone is a molecule used to treat stroke and amyotrophic lateral sclerosis (ALS).

The mechanism of action is not fully understood, but it is known to act as an antioxidant, potentially reducing oxidative stress, which is implicated in neuron damage in ALS and stroke.

Clinical trials have shown mixed results, with some studies suggesting benefits in early-stage ALS patients. The drug is also being investigated for long-term safety and efficacy.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Edaravone
https://www.medchemexpress.com/Edaravone.html
https://www.medkoo.com/products/11092
https://go.drugbank.com/drugs/DB12243
https://www.als.org/navigating-als/living-with-als/fda-approved-drugs/edaravone